Lanhine is a renowned brand established in 2007, specializing in material and product development. With a strong focus on respiratory and adsorption materials, Lanhine has excelled in the development and application of medical masks, particularly for children. In fact, Lanhine played a key role in drafting the national standards for children's masks, ensuring the highest quality and safety.

Since 2015, Lanhine has ventured into the field of traditional Chinese medicine, plant extracts, and botanical oils, combining them with medical device products. This strategic move has allowed Lanhine to expand its offerings and meet the growing demand for innovative healthcare solutions. Recognizing the brand's potential, Lanhine secured strategic investments from well-established enterprises, including Xinhua Medical and Qinyuan Group, in 2017 and 2018 respectively.

These investments have injected significant momentum into Lanhine's development. Committed to innovation, Lanhine invests nearly 65% of its annual budget in research and development, resulting in over 50 innovative patents. The company also maintains a robust quality production system, complying with domestic GMP and European CE standards, and has obtained various certifications such as CFDA, CE, ISO, QS, and SGS.

With a strong R&D capability, efficient management system, and extensive market resources, Lanhine has successfully established a presence in over 60 countries worldwide. This global reach allows the brand to swiftly bring its cutting-edge healthcare products to market. Lanhine's dedication to technological advancement, exceptional customer service, and stellar market reputation have propelled its success.

As the brand continues to grow amidst fierce international competition and ever-changing times, Lanhine pledges to collaborate sincerely with partners from all walks of life, fostering mutual development and building a more prosperous future